{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:10:15Z","timestamp":1792113015658,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.bbi.2009.04.008","type":"journal-article","created":{"date-parts":[[2009,5,5]],"date-time":"2009-05-05T05:05:50Z","timestamp":1241499950000},"page":"1079-1082","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"title":["Abnormalities in serum chemokine levels in euthymic patients with Bipolar Disorder"],"prefix":"10.1016","volume":"23","author":[{"given":"Elisa","family":"Brietzke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcia","family":"Kauer-Sant\u2019Anna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f4nio L\u00facio","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1vio","family":"Kapczinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2009.04.008_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0165-0327(01)00377-9","article-title":"Mortality of patients with mood disorders: follow-up over 34\u201338 years","volume":"68","author":"Angst","year":"2002","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2009.04.008_bib2","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.pnpbp.2008.01.006","article-title":"TNF-alpha as a molecular target in bipolar disorder","volume":"32","author":"Brietzke","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2009.04.008_bib3","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The many roles of chemokines and chemokines receptors in inflammation","volume":"354","author":"Charo","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2009.04.008_bib4","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.schres.2008.03.018","article-title":"Patients with schizophrenia show raised serum levels of the pro-inflammatory chemokine CCL2: association with the metabolic syndrome in patients?","volume":"102","author":"Drexhage","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2009.04.008_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jad.2008.07.022","article-title":"Immune system dysregulation in adolescent major depressive disorder","volume":"115","author":"Gabbay","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2009.04.008_bib6","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archneur.63.4.538","article-title":"Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease","volume":"63","author":"Galimberti","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbi.2009.04.008_bib7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0006-8993(99)02439-7","article-title":"Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NFkappaB","volume":"857","author":"Ichiyama","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2009.04.008_bib8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1440-1819.2007.01686.x","article-title":"T helper 1\/T helper 2 cytokine imbalance and clinical phenotypes in acute-phase major depressive disorder","volume":"61","author":"Huang","year":"2007","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbi.2009.04.008_bib9","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1586\/14737175.8.7.1101","article-title":"Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder","volume":"8","author":"Kapczinski","year":"2008","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.bbi.2009.04.008_bib10","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neubiorev.2007.10.005","article-title":"Allostatic load in bipolar disorder: implications for pathophysiology and treatment","volume":"32","author":"Kapczinski","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2009.04.008_bib11","first-page":"1","article-title":"Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder","volume":"4","author":"Kauer-Sant\u2019anna","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2009.04.008_bib12","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.pnpbp.2004.05.047","article-title":"Th1, Th2 and Th3 cytokine alteration in schizophrenia","volume":"28","author":"Kim","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2009.04.008_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2007.02.018","article-title":"Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder","volume":"104","author":"Kim","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2009.04.008_bib14","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neulet.2008.03.019","article-title":"Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer\u2019s disease","volume":"436","author":"Kim","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbi.2009.04.008_bib15","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1399-5618.2007.00444.x","volume":"7","author":"Knijff","year":"2007","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.bbi.2009.04.008_bib16","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1001\/jama.293.20.2528","article-title":"The increasing medical burden in bipolar disorder","volume":"293","author":"Kupfer","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.bbi.2009.04.008_bib17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/978-1-4020-8830-8_12","article-title":"The role of phospholipid oxidation products in inflammatory and autoimmune diseases: evidence from animal models and in humans","volume":"49","author":"Leitinger","year":"2008","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.bbi.2009.04.008_bib18","doi-asserted-by":"crossref","first-page":"6197","DOI":"10.1073\/pnas.090105997","article-title":"The chemokine growth-related gene product beta protects rat cerebellar granule cells from apoptotic cell death through alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors","volume":"97","author":"Limatola","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbi.2009.04.008_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jneuroim.2005.03.023","article-title":"Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity","volume":"166","author":"Limatola","year":"2005","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.bbi.2009.04.008_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/84298","article-title":"Chemokines: immunology\u2019s high impact factors","volume":"2001","author":"Mackay","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbi.2009.04.008_bib21","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0006-3223(03)00177-X","article-title":"Mood disorders and allostatic load","volume":"54","author":"McEwen","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2009.04.008_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/09511920410001713484","article-title":"Involvement of fractalkine and macrophage inflammatory protein-1 alpha in moderate\u2013severe depression","volume":"13","author":"Merendino","year":"2004","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.bbi.2009.04.008_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1600-0404.2006.00629.x","article-title":"Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis","volume":"114","author":"Moreira","year":"2006","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.bbi.2009.04.008_bib24","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1182\/blood.V95.10.3032","article-title":"Chemokine receptors and their role in inflammation and infectious diseases","volume":"95","author":"Murdoch","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbi.2009.04.008_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jad.2005.07.008","article-title":"Th1, Th2, and Th3 cytokine alterations in major depression","volume":"88","author":"Myint","year":"2005","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2009.04.008_bib26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hup.912","article-title":"Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study","volume":"23","author":"Nery","year":"2008","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.bbi.2009.04.008_bib27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jad.2005.11.015","article-title":"Cytokine profiles in bipolar affective disorder: focus on acutely ill patients","volume":"90","author":"O\u2019Brien","year":"2006","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2009.04.008_bib28","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0169-409X(98)00086-6","article-title":"Penetration of neurotrophins and cytokines across the blood\/brain\/blood\/spinal cord barrier","volume":"36","author":"Pan","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbi.2009.04.008_bib29","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jpsychires.2006.09.009","article-title":"Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications","volume":"41","author":"Post","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2009.04.008_bib30","doi-asserted-by":"crossref","first-page":"10488","DOI":"10.1523\/JNEUROSCI.3192-06.2006","article-title":"Chemokine fractalkine\/CX3CL1 negatively modulates active glutamatergic synapses in rat hippocampal neurons","volume":"26","author":"Ragozzino","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2009.04.008_bib31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3233\/JAD-2008-14203","article-title":"Peripheral chemokine receptors, their ligands, cytokines and Alzheimer\u2019s disease","volume":"14","author":"Reale","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbi.2009.04.008_bib32","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nrn2255","article-title":"Chemokines: a new class of neuromodulator?","volume":"8","author":"Rost\u00e8ne","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbi.2009.04.008_bib33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/sj.npp.1301575","article-title":"Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder","volume":"33","author":"Schloesser","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2009.04.008_bib34","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.euroneuro.2007.06.004","article-title":"A detailed examination of cytokine abnormalities in major depressive disorder","volume":"18","author":"Simon","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2009.04.008_bib35","doi-asserted-by":"crossref","unstructured":"Soczynska, J., Kennedy, S.H., Goldstein, B.I., Lachowski, A., Woldeyohannes, H., McIntyre, R.S., in press. The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: novel hypothesis-driven treatments for bipolar depression? Neurotoxicology. doi:10.1016\/j.neuro.2009.03.004.","DOI":"10.1016\/j.neuro.2009.03.004"},{"key":"10.1016\/j.bbi.2009.04.008_bib36","doi-asserted-by":"crossref","first-page":"76396","DOI":"10.1155\/2007\/76396","article-title":"Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy","volume":"2007","author":"Sutcigil","year":"2007","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.bbi.2009.04.008_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1742-2094-5-11","article-title":"Neuronal apoptosis and inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-2","volume":"5","author":"Takahashi","year":"2008","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.bbi.2009.04.008_bib38","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.pnpbp.2007.11.019","article-title":"Increased serum levels of CCL11\/eotaxin in schizophrenia","volume":"32","author":"Teixeira","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2009.04.008_bib39","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1124\/mol.104.004812","article-title":"Macrophage inflammatory protein 2 inhibits \u03b2-amyloid peptide (1\u201342)-mediated hippocampal neuronal apoptosis through activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways","volume":"67","author":"Watson","year":"2005","journal-title":"Mol. Pharmacol."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159109001111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159109001111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:22:40Z","timestamp":1760167360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159109001111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0889159109001111"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2009.04.008","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abnormalities in serum chemokine levels in euthymic patients with Bipolar Disorder","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2009.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}